(EMSG) DBX Trust - Xtrackers MSCI - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US2330512268
EMSG: Equity, Securities, ESG, Emerging, Leaders
The DBX ETF Trust - Xtrackers MSCI Emerging Markets ESG Leaders Equity ETF (EMSG) is an exchange-traded fund that tracks a subset of the MSCI ACWI Select Climate500 Index, focusing on emerging markets companies that demonstrate strong ESG (Environmental, Social, and Governance) leadership. By investing at least 80% of its assets in component securities of the underlying index, the fund provides exposure to a curated selection of emerging markets stocks that are expected to outperform their peers in terms of climate and ESG metrics.
Given its non-diversified nature, EMSG is likely to be more sensitive to sector-specific trends and company-specific risks. However, its focus on ESG leaders may also provide a degree of resilience to environmental and social risks. The funds underlying index is designed to capture the performance of approximately 500 stocks, providing a relatively broad coverage of the emerging markets universe.
From a technical analysis perspective, EMSGs recent price action suggests a bullish trend, with the last price of $29.64 exceeding both the 20-day and 50-day simple moving averages (SMA20 and SMA50). The stock is also trading near its 52-week high, indicating strong momentum. The average true range (ATR) of 0.50, or 1.70%, suggests moderate volatility. Considering these technical indicators, a potential forecast is that EMSG may continue to trend upwards, potentially reaching new 52-week highs in the near term.
Fundamentally, EMSGs assets under management (AUM) stand at $198.54 million, indicating a relatively modest but still significant investor base. As the fund continues to attract investors seeking ESG-focused emerging markets exposure, its AUM is likely to grow. Combining this fundamental insight with the technical analysis, a potential forecast is that EMSG may experience sustained inflows, driving its price higher and potentially reaching $31.50 within the next 6-12 months, representing a 6-7% upside from current levels.
Additional Sources for EMSG ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
EMSG ETF Overview
Market Cap in USD | 303m |
Category | Diversified Emerging Mkts |
TER | 0.20% |
IPO / Inception | 2018-12-04 |
EMSG ETF Ratings
Growth Rating | 10.2 |
Fundamental | - |
Dividend Rating | 6.10 |
Rel. Strength | 6.97 |
Analysts | - |
Fair Price Momentum | 29.74 USD |
Fair Price DCF | - |
EMSG Dividends
Dividend Yield 12m | 0.86% |
Yield on Cost 5y | 1.03% |
Annual Growth 5y | -25.78% |
Payout Consistency | 62.7% |
Payout Ratio | % |
EMSG Growth Ratios
Growth Correlation 3m | 91.2% |
Growth Correlation 12m | 63% |
Growth Correlation 5y | -36.9% |
CAGR 5y | 5.19% |
CAGR/Max DD 5y | 0.11 |
Sharpe Ratio 12m | 0.44 |
Alpha | 10.23 |
Beta | 0.753 |
Volatility | 16.50% |
Current Volume | 7513.3k |
Average Volume 20d | 3.2k |
As of July 01, 2025, the stock is trading at USD 31.36 with a total of 7,513,333 shares traded.
Over the past week, the price has changed by +3.74%, over one month by +7.32%, over three months by +12.49% and over the past year by +22.12%.
Neither. Based on ValueRay´s Analyses, DBX Trust - Xtrackers MSCI is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 10.23 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of EMSG is around 29.74 USD . This means that EMSG is currently overvalued and has a potential downside of -5.17%.
DBX Trust - Xtrackers MSCI has no consensus analysts rating.
According to our own proprietary Forecast Model, EMSG DBX Trust - Xtrackers MSCI will be worth about 34.2 in July 2026. The stock is currently trading at 31.36. This means that the stock has a potential upside of +9.15%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 34.2 | 9.2% |